TITLE

Extracting Maximum Value from Your Patent Portfolio

AUTHOR(S)
Kaufman, Craig R.
PUB. DATE
May 2003
SOURCE
BioPharm International;May2003, Vol. 16 Issue 5, p24
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Discusses the importance of market surveillance and an effective litigation or licensing strategy for effective use of a patent portfolio in the biopharmaceutical industry. Prelitigation techniques; Infringement detection; Imposition of notice requirement on patent owners.
ACCESSION #
9674674

 

Related Articles

  • OTHER NEWS TO NOTE.  // BioWorld Today;1/16/2008, Vol. 19 Issue 11, p7 

    This section offers news briefs related to the biopharmaceutics sector. ActivBiotics Inc. has extended the deadline by which interested parties can bid to purchase its assets. A subgrant award was received by Arteriocyte Inc. to further develop its technology. A license agreement was signed...

  • OTHER NEWS TO NOTE.  // BioWorld Today;12/3/2007, Vol. 18 Issue 233, p2 

    This section offers news briefs about the biopharmaceutics industry. ChemDiv Inc. was chosen by Orion Pharma as a partner to deploy its Discovery outSource platform to create small-molecule therapeutics for Orion's targets. Celgene International Sarl has received orphan drug status from the...

  • Emerging issues in research tool licensing. Bersin, Brent; Bratic, Walt; McLane, Patrick // Journal of Commercial Biotechnology;Autumn2001, Vol. 8 Issue 2, p106 

    This paper presents a brief examination of the current trends and issues in the licensing of patented research tools, as well as perspectives on 'reach through' licensing of research tools.

  • Excimer Lasers: A Change in the Patent Landscape?  // Review of Ophthalmology;Jun2001 Part 1 of 2, Vol. 8 Issue 6, p10 

    Reports the request of LaserSight for a license agreement with other competitors in the United States. Re-issuance plan for the patent governing scanning ultraviolet laser technology; Fundamental claims of the patent; Impact of the agreement on the operations of LaserSight.

  • U.S. Patent Disclosures.  // BioWorld Today;10/17/2011, Vol. 22 Issue 201, p7 

    The article offers an update on patents received by biopharmaceutical companies in the U.S. as of October 2011 including Anthera Pharmaceuticals Inc., Cortex Pharmaceuticals Inc. and Curemark LLC.

  • Opportunities and Challenges in Licensing. Adams, Nicholas; Best, Simon; Scoular, Ian // Pharmaceutical Licensing: Deal Sourcing & Metrics;2007, p8 

    The article reports on the challenges and opportunities in licensing in the pharmaceutical and biotechnology industries in Great Britain. It examines the factors that drive the licensing deals within the life sciences sector to secure financing in drug development through deal-making activity....

  • Avoiding Late-stage Licensing Pitfalls. Colpman, David // Pharmaceutical Licensing: Deal Sourcing & Metrics;2007, p15 

    The article reports on the potential risks in late-stage licensing deals in the pharmaceutical and biotechnology industries in Great Britain. It provides an overview of the deal-making activity and the licensing agreement process within the industry and the implications of these transactions on...

  • Partnering Perspectives - Co-dependence and Independence. Gribbon, Enda // Pharmaceutical Licensing: Deal Sourcing & Metrics;2007, p18 

    The article reports on the importance of co-dependence and independence in partnering between pharmaceutical and biotechnology companies in Great Britain. It provides an overview of the partnering transactions within the industry, along with the key drivers in deal-making such as drug research...

  • The Science of Alliance Funding. Kumli, Frank; Flochel, Patrick // Pharmaceutical Licensing: Deal Sourcing & Metrics;2007, p21 

    The article reports on the significance of pharmaceutical-biotechnology alliances in reducing the risks and uncertainties in drug discovery and development in Great Britain. It provides an overview of the partnering activities within the industry and the trend towards a collaborative approach to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics